Helicobacter pylori Infection and Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

被引:22
作者
Heydari, Keyvan [1 ,2 ]
Yousefi, Mohammad [3 ]
Alizadeh-Navaei, Reza [2 ]
Lotfi, Parisa [1 ]
Sheydaee, Fateme [3 ]
Raei, Maedeh [4 ]
Vahdatinia, Alireza [1 ]
Hessami, Amirhossein [1 ]
Rafati, Sajjad [1 ]
Moosazadeh, Mahmood [2 ]
Ghasemian, Roya [5 ]
Salehi, Fatemeh [6 ]
Massoudi, Haleh [7 ]
Ghaffari-Saravi, Fatemeh [8 ]
Rismantab, Sahar [7 ]
机构
[1] Mazandaran Univ Med Sci, Fac Med, Student Res Comm, Sari, Iran
[2] Mazandaran Univ Med Sci, Gastrointestinal Canc Res Ctr, Noncommunicable Dis Inst, Sari, Iran
[3] Semnan Univ Med Sci, Dept Med, Fac Med, Semnan, Iran
[4] Islamic Azad Univ, Fac Med, Sari Branch, Sari, Iran
[5] Mazandaran Univ Med Sci, Antimicrobial Resistance Res Ctr, Dept Infect Dis, Sari, Iran
[6] Islamic Azad Univ, Dept Pathol, Sari Branch, Fac Med, Sari, Iran
[7] Mazandaran Univ Med Sci, Ramsar Campus, Ramsar, Iran
[8] Mazandaran Univ Med Sci, Tradit & Complementary Med Res Ctr, Addict Inst, Sari, Iran
关键词
Fatty liver; Helicobacter; meta-analysis; steatohepatitis; NONALCOHOLIC STEATOHEPATITIS; HEPATIC-FIBROSIS; PREVALENCE; NAFLD;
D O I
10.5152/tjg.2022.21467
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Since numerous studies have stated that there may be a relationship between Helicobacter pylon infection and nonalcoholic fatty liver disease and because of the high prevalence of both conditions worldwide, this study investigated the risk of non-alcoholic fatty liver in patients liver disease in patients infected with H. pylon. Following a systematic review of PubMed, Scopus, Web of Science and Embase, and a search in Google Scholar using MeSH terms such as H. pylon and non-alcoholic fatty liver disease, the relevant papers up to November 2020 were reviewed. All cohort, case-control, and cross-sectional studies that examined the risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori entered this study. A meta-analysis was conducted in STATA 11. This systematic review examined 22 papers with 117 117 participants (33 711 patients infected with H pylori and 83 406 participants as control) and 20 studies were subjected to meta-analysis The results indicated a 22% to 27% increase in the risk of developing non-alcoholic fatty liver disease in patients infected with H. pylori (crude odds ratio: 1.27, 95% CI 1.17-1.33; and adjusted odds ratio: 1.22, 95% CI: 1.09-1.35). According to the subgroup analysis, the study region, sample size, and the method of diagnosing H. pylori were the factors contributing to the high heterogeneity. The meta-analysis revealed the increased risk of developing non-alcoholic fatty liver disease in patients infected with H. pylon TI is indicates that H. pylori is a serious risk factor in patients susceptible to NAFLD.
引用
收藏
页码:171 / 181
页数:11
相关论文
共 50 条
[1]   Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study [J].
Abdel-Razik, Ahmed ;
Mousa, Nasser ;
Elhelaly, Rania ;
Elzehery, Rasha ;
Hasan, Ahmad S. ;
Abdelsalam, Mostafa ;
Seif, Ahmed Salah ;
Tawfik, Ahmed M. ;
El-Wakeel, Niveen ;
Eldars, Waleed .
FRONTIERS IN MEDICINE, 2020, 7
[2]   Helicobacter pylori and non-alcoholic fatty liver disease: A new enigma? [J].
Abdel-Razik, Ahmed ;
Mousa, Nasser ;
Shabana, Walaa ;
Refaey, Mohamed ;
Elhelaly, Rania ;
Elzehery, Rasha ;
Abdelsalam, Mostafa ;
Elgamal, Ayman ;
Nassar, Mervat R. ;
Abu El-Soud, Atef ;
Seif, Ahmed S. ;
Tawfik, Ahmed M. ;
El-Wakeel, Niveen ;
Eldars, Waleed .
HELICOBACTER, 2018, 23 (06)
[3]   Relationship Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease (NAFLD) in a Developing Country: A Cross-Sectional Study [J].
Abo-Amer, Yousry Esam-Eldin ;
Sabal, Aisha ;
Ahmed, Rehab ;
Hasan, Nabil Fathy Esmael ;
Refaie, Rasha ;
Mostafa, Sahar Mohamed ;
Mohamed, Ahmed Abdelhaleem ;
Khalil, Mahmoud ;
Elagawy, Waleed ;
Abd-Elsalam, Sherief .
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 :619-625
[4]   Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large US Claims Database [J].
Allen, Alina M. ;
Van Houten, Holly K. ;
Sangaralingham, Lindsey R. ;
Talwalkar, Jayant A. ;
McCoy, Rozalina G. .
HEPATOLOGY, 2018, 68 (06) :2230-2238
[5]   Associations betweenHelicobacter pyloriwith nonalcoholic fatty liver disease and other metabolic conditions in Guatemala [J].
Alvarez, Christian S. ;
Florio, Andrea A. ;
Butt, Julia ;
Rivera-Andrade, Alvaro ;
Kroker-Lobos, Maria F. ;
Waterboer, Tim ;
Camargo, Maria Constanza ;
Freedman, Neal D. ;
Graubard, Barry I. ;
Lazo, Mariana ;
Guallar, Eliseo ;
Groopman, John D. ;
Ramirez-Zea, Manuel ;
McGlynn, Katherine A. .
HELICOBACTER, 2020, 25 (06)
[6]   Helicobacter pylori infection is not associated with nonalcoholic fatty liver disease [J].
Baeg, Myong Ki ;
Yoon, Seung Kew ;
Ko, Sun-Hye ;
Noh, Yong-Sun ;
Lee, In-Seok ;
Choi, Myung-Gyu .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (08) :2592-2600
[7]   Nonalcoholic Fatty Liver Disease and Obesity Treatment [J].
Brunner, Katherine T. ;
Henneberg, Cameron J. ;
Wilechansky, Robert M. ;
Long, Michelle T. .
CURRENT OBESITY REPORTS, 2019, 8 (03) :220-228
[8]   Association between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease: A Single-Center Clinical Study [J].
Cai, Ou ;
Huang, Zhenpeng ;
Li, Ming ;
Zhang, Chaoqun ;
Xi, Fengbo ;
Tan, Shiyun .
GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
[9]   Possible association between Helicobacter pylori infection and nonalcoholic fatty liver disease [J].
Chen, Chang-Xi ;
Mao, Yu-Shan ;
Foster, Parker ;
Zhu, Zhong-Wei ;
Du, Juan ;
Guo, Chuan-Yong .
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2017, 42 (03) :295-301
[10]   Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients [J].
Doulberis, Michael ;
Srivastava, Simone ;
Polyzos, Stergios A. ;
Kountouras, Jannis ;
Papaefthymiou, Apostolis ;
Klukowska-Rotzler, Jolanta ;
Blank, Annika ;
Exadaktylos, Aristomenis K. ;
Srivastava, David S. .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)